Clorox (CLX) PT Lowered to $195 at Jefferies
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Pre-Open Stock Movers 05/03: (MDP) (OCGN) (VIRX) Higher; (VXRT) (PETS) (EL) Lower (more...)
May 3, 2021 9:30 AM EDTToday's Pre-Open Stock Movers
Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) 33% HIGHER; adds to recent momentum gains.
Meredith Corporation (NYSE: MDP) 12.5% HIGHER; today announced that it has agreed to sell its Local Media Group ("LMG") to Gray Television, Inc. (NYSE: GTN) for $2.7 billion in cash and will focus exclusively on its... More
Wells Fargo Downgrades Clorox (CLX) Two-Notches to 'Underweight', Calls 'Dead Money' at Best
May 3, 2021 8:21 AM EDTWells Fargo analyst Chris Carey downgrade the Clorox Company (NYSE: CLX) to Underweight from Overweight after the company slashed its 2022 guidance.
CLX stock closed over 3% lower last week after forecasting narrowing margins this year while revenues missed expectations. Quarterly sales came in at $1.78 billion to miss on the $1.86 billion projected by analysts.
Well activate our long-standing cost savings program and ensure that were delivering that across our businesses. Were looking at price increases, although were being very measured and taking that in a category-by-category approach and,... More
Clorox (CLX) PT Lowered to $177 at DA Davidson
May 3, 2021 7:28 AM EDTDA Davidson analyst Linda Bolton Weiser lowered the price target on Clorox (NYSE: CLX) to $177.00 (from $189.00) while maintaining a Neutral rating.
The analyst commented, "CLX reported a F3Q21 EPS upside surprise, but missed consensus sales expectations, with Health & Wellness -8%... More
Clorox (CLX) PT Lowered to $186 at Deutsche Bank
May 3, 2021 6:51 AM EDTDeutsche Bank analyst Stephen Powers lowered the price target on Clorox (NYSE: CLX) to $186.00 (from $195.00) while maintaining a Hold rating.... More
Wells Fargo Downgrades Clorox (CLX) to Underweight; 'Dead Money at Best'
May 3, 2021 6:31 AM EDT(Updated - May 3, 2021 6:39 AM EDT)
Wells Fargo analyst Chris Carey downgraded Clorox (NYSE: CLX) from Overweight to Underweight, PT $170 (from $240.00).
The analyst comments "We are downgrading shares of CLX to Underweight from Overweight and lowering our price target to $170... More
Clorox (CLX) PT Lowered to $219 at Citi
May 3, 2021 5:17 AM EDTCiti analyst Wendy Nicholson lowered the price target on Clorox (NYSE: CLX) to $219.00 (from $249.00) while maintaining a Buy rating.... More
Clorox (CLX) PT Lowered to $185 at Credit Suisse
May 3, 2021 5:14 AM EDTCredit Suisse analyst Kaumil Gajrawala lowered the price target on Clorox (NYSE: CLX) to $185.00 (from $205.00) while maintaining a Neutral rating.... More
Clorox (CLX) PT Lowered to $170 at Morgan Stanley
May 3, 2021 4:08 AM EDTMorgan Stanley analyst Dara Mohsenian lowered the price target on Clorox (NYSE: CLX) to $170.00 (from $183.00) while maintaining a Underweight rating.... More
Clorox (CLX) to raise prices on GLAD products in July - Bloomberg
April 30, 2021 1:47 PM EDTClorox (NYSE: CLX) to raise prices on GLAD products in July - Bloomberg
... MoreClorox (CLX) Tops Q3 EPS by 14c, Revenue Misses, Guides Below Consensus
April 30, 2021 6:38 AM EDTClorox (NYSE: CLX) reported Q3 EPS of $1.62, $0.14 better than the analyst estimate of $1.48. Revenue for the quarter came in at $1.78 billion versus the consensus estimate of $1.87 billion.
GUIDANCE:
Clorox sees FY2021 EPS of $7.45-$7.65, versus the consensus of $8.35.
10% to 13% sales growth (10% to 13% organic sales growth)$5.94 to $6.14 diluted EPS range (19% to 16% decrease versus year ago)$7.45 to $7.65 adjusted EPS range (1% to 4% increase versus year ago)Excludes the $2.11 loss from the noncash impairment related to the VMS business and the 60-cent one-time noncash gain from the Saudi JV acquisition... More